Bonan Chen

机构：Jiangsu University, Shenzhen Institute of Information Technology, Chinese University of Hong Kong, City University of Hong Kong, Shenzhen Research Institute, Prince of Wales Hospital, Chinese University of Hong Kong, Shenzhen, University of Hong Kong · ORCID：0000-0002-2430-7934

发表论文 138 篇 · 总被引 2166 次 · h-index 28

代表论文

• Prevalence of MASLD and fibrosis assessed by transient elastography in U.S. adolescents: insights from NHANES 2017-2023 (2025 · Diabetology & Metabolic Syndrome · 被引 2)
• The role of Chinese medicines in targeting non-coding RNAs to overcome cancer drug resistance: Mechanisms and clinical translation challenges (2025 · Pharmacological Research · 被引 2)
• Development and validation of an explainable machine learning model using routine laboratory biomarkers for identifying prevalent MASLD: Evidence from two observational studies (2026 · Clinical and Experimental Medicine · 被引 1)
• Lab resource: single cell line generation of an induced pluripotent stem cell line UJSi006-A from a patient with ultra-treatment-resistant schizophrenia (2026 · Stem Cell Research)
• HES1 inhibition overcomes CDK4/6 inhibitor resistance by targeting cancer stemness in lung adenocarcinoma (2026 · Journal of Experimental & Clinical Cancer Research)
• Trends in MASLD-related cirrhosis and liver cancer across diverse populations, 2010–2023 (2026 · Hepatology International)